A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer

被引：0

作者：

Soukupova, Jana ^{[1
,2
]}

Stastna, Barbora ^{[1
,2
,3
,4
]}

Kanwal, Madiha ^{[3
]}

Hojny, Jan ^{[2
,5
]}

Zemankova, Petra ^{[1
,2
,6
]}

Borecka, Marianna ^{[1
,2
]}

Cerna, Leona ^{[7
]}

Cerna, Marta ^{[1
,2
]}

Cerna, Monika ^{[8
]}

Curtisova, Vaclava ^{[9
]}

Dolezalova, Tatana ^{[1
,2
]}

Duskova, Petra ^{[10
]}

Foretova, Lenka ^{[11
]}

Havranek, Ondrej ^{[2
,12
,13
]}

Horackova, Klara ^{[1
,2
]}

Hovhannisyan, Milena ^{[1
,2
]}

Hruskova, Lucie ^{[14
]}

Chvojka, Stepan ^{[7
]}

Janatova, Marketa ^{[1
,2
]}

Janikova, Maria ^{[9
]}

Jelinkova, Sandra ^{[1
,2
]}

Just, Pavel ^{[1
,2
]}

Kalousova, Marta ^{[1
,2
]}

Kleiblova, Petra ^{[1
,2
,12
]}

Kosarova, Marcela ^{[15
]}

Koudova, Monika ^{[7
]}

Kral, Jan ^{[1
,2
]}

Krausova, Michaela ^{[2
,5
]}

Krutilkova, Vera ^{[16
]}

Machackova, Eva ^{[11
]}

Matejkova, Katerina ^{[1
,2
,17
]}

Michalovska, Renata ^{[14
]}

Nehasil, Petr ^{[1
,2
,6
,18
]}

Nemcova, Barbora ^{[1
,2
]}

Novotny, Jan ^{[2
,12
,19
]}

Palek, Matous ^{[3
]}

Pesek, Pavel ^{[1
,2
]}

Safarikova, Marketa ^{[1
,2
]}

Scheinost, Ondrej ^{[10
]}

Springer, Drahomira ^{[1
,2
]}

Stolarova, Lenka ^{[3
]}

Stranecky, Viktor ^{[2
,18
]}

Subrt, Ivan ^{[8
]}

Tavandzis, Spiros ^{[16
]}

Tureckova, Eva ^{[1
,2
]}

Vesela, Kamila ^{[2
,12
]}

Vlckova, Zdenka ^{[14
]}

Vocka, Michal ^{[2
,20
]}

Zima, Tomas ^{[1
,2
]}

Macurek, Libor ^{[3
]}

机构：

[1] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Fac Med 1, Katerinska 32, Prague 12108, Czech Republic

[2] Gen Univ Hosp Prague, Katerinska 32, Prague 12108, Czech Republic

[3] Czech Acad Sci, Inst Mol Genet, Lab Canc Cell Biol, Videnska 1034, Prague 14220, Czech Republic

[4] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic

[5] Charles Univ Prague, Inst Pathol, Fac Med 1, Prague, Czech Republic

[6] Charles Univ Prague, Inst Pathol Physiol, Fac Med 1, Prague, Czech Republic

[7] Ctr Med Genet & Reprod Med, GENNET, Prague, Czech Republic

[8] Univ Hosp Plzen, Inst Med Genet, Plzen, Czech Republic

[9] Palacky Univ, Univ Hosp Olomouc, Fac Med & Dent, Dept Med Genet, Olomouc, Czech Republic

[10] Hosp Ceske Budejovice, Ceske Budejovice, Czech Republic

[11] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic

[12] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic

[13] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec, Czech Republic

[14] GHC Genet, Dept Med Genet, Prague, Czech Republic

[15] Pronatal, Dept Med Genet, Prague, Czech Republic

[16] AGEL Res & Training Inst, Dept Med Genet, AGEL Labs, Novy Jicin, Czech Republic

[17] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic

[18] Charles Univ Prague, Dept Paediat & Inherited Metab Disorders, Fac Med 1, Prague, Czech Republic

[19] Inst Clin & Expt Med, Prague, Czech Republic

[20] Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic

来源：

CANCER MEDICINE | 2024年 / 13卷 / 16期

关键词：

breast cancer; Fanconi anemia complementation group G; functional analysis; germline genetic testing; hereditary tumors; ovarian cancer; ANEMIA; ASSOCIATION; REPAIR;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Monoallelic germline pathogenic variants (GPVs) in five Fanconi anemia (FA) genes (BRCA1/FANCS, BRCA2/FANCD1, PALB2/FANCN, BRIP1/FANCJ, and RAD51C/FANCO) confer an increased risk of breast (BC) and/or ovarian (OC) cancer, but the role of GPVs in 17 other FA genes remains unclear. Methods: Here, we investigated the association of germline variants in FANCG/XRCC9 with BC and OC risk. Results: The frequency of truncating GPVs in FANCG did not differ between BC (20/10,204; 0.20%) and OC (8/2966; 0.27%) patients compared to controls (6/3250; 0.18%). In addition, only one out of five tumor samples showed loss-of-heterozygosity of the wild-type FANCG allele. Finally, none of the nine functionally tested rare recurrent missense FANCG variants impaired DNA repair activities (FANCD2 monoubiquitination and FANCD2 foci formation) upon DNA damage, in contrast to all tested FANCG truncations. Conclusion: Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.

引用

页数：9

共 50 条

[1] Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer
Rolfes, Muriel
Borde, Julika
Moellenhoff, Kathrin
Kayali, Mohamad
Ernst, Corinna
Gehrig, Andrea
Sutter, Christian
Ramser, Juliane
Niederacher, Dieter
Horvath, Judit
Arnold, Norbert
Meindl, Alfons
Auber, Bernd
Rump, Andreas
Wang-Gohrke, Shan
Ritter, Julia
Hentschel, Julia
Thiele, Holger
Altmueller, Janine
Nuernberg, Peter
Rhiem, Kerstin
Engel, Christoph
Wappenschmidt, Barbara
Schmutzler, Rita K.
Hahnen, Eric
Hauke, Jan
CANCERS, 2022, 14 (13)
[2] Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
Quezada Urban, Rosalia
Diaz Velasquez, Clara Estela
Gitler, Rina
Rojo Castillo, Maria Patricia
Sirota Toporek, Max
Figueroa Morales, Andrea
Moreno Garcia, Oscar
Garcia Esquivel, Lizbeth
Torres Mejia, Gabriela
Dean, Michael
Delgado Enciso, Ivan
Diaz Lopez, Hector Ochoa
Rodriguez Leon, Fernando
Jan, Virginia
Garzon Barrientos, Victor Hugo
Ruiz Flores, Pablo
Espino Silva, Perla Karina
Haro Santa Cruz, Jorge
Martinez Gregorio, Hector
Rojas Jimenez, Ernesto Arturo
Romero Cruz, Luis Enrique
Mendez Catala, Claudia Fabiola
Alvarez Gomez, Rosa Maria
Fragoso Ontiveros, Veronica
Alonso Herrera, Luis
Romieu, Isabelle
Ignacio Terrazas, Luis
Irasema Chirino, Yolanda
Frecha, Cecilia
Oliver, Javier
Perdomo, Sandra
Vaca Paniagua, Felipe
CANCERS, 2018, 10 (10):
[3] Comprehensive analysis of germline variants in Mexican patients with hereditary breast and ovarian cancer susceptibility
Vaca-Paniagua, Felipe
Quezada-Urban, Rosalia
Diaz-Velasquez, Clara E.
Gitler, Rina
Rojo-Castillo, Maria P.
Sirota-Toporek, Max
Figueroa-Morales, Andrea
Moreno-Garcia, Oscar
Garcia Esquivel, Lizbeth
Torres-Mejia, Gabriela
Dean, Michael
Delgado-Enciso, Ivan
Ochoa-Diaz-Lopez, Hector
Rodriguez-Leon, Fernando
Jan, Virginia
Hugo Garzon-Barrientos, Victor H.
Ruiz-Flores, Pablo
Espino-Silva, Perla K.
Haro-Santa Cruz, Jorge
Martinez-Gregorio, Hector
Rojas-Jimenez, Ernesto
Alvarez-Gomez, Rosa M.
Herrera, Luis A.
Romieu, Isabelle
Terrazas, Luis I.
Chirino, Yolanda I.
Frecha, Cecilia
Oliver, Javier
Perdomo, Sandra
CANCER RESEARCH, 2018, 78 (13)
[4] A comprehensive analysis of germline predisposition to early-onset ovarian cancer
Horackova, Klara
Zemankova, Petra
Nehasil, Petr
Vocka, Michal
Hovhannisyan, Milena
Matejkova, Katerina
Janatova, Marketa
Cerna, Marta
Kleiblova, Petra
Jelinkova, Sandra
Stastna, Barbora
Just, Pavel
Dolezalova, Tatana
Nemcova, Barbora
Urbanova, Marketa
Koudova, Monika
Hazova, Jana
Machackova, Eva
Foretova, Lenka
Stranecky, Viktor
Zikan, Michal
Kleibl, Zdenek
Soukupova, Jana
SCIENTIFIC REPORTS, 2024, 14 (01):
[5] Role of Functional Non Coding Variants in the Germline DNA in the Ovarian Cancer Predisposition
Ezquina, Suzana A. M.
Dicks, Ed
Corona, Rosario I.
Lawrenson, Kate
Gayther, Simon
Jones, Michelle R.
Freedman, Matthew L.
Drapkin, Ronny
Pharoah, Paul
GENETIC EPIDEMIOLOGY, 2019, 43 (07) : 878 - 879
[6] Comprehensive Care of Women With Genetic Predisposition to Breast and Ovarian Cancer
AlHilli, Mariam M.
Batur, Pelin
Hurley, Karen
Al-Hilli, Zahraa
Coombs, Demetrius
Schwarz, Graham
Djohan, Risal
Marquard, Jessica
Ashton, Kathleen
Pederson, Holly J.
MAYO CLINIC PROCEEDINGS, 2023, 98 (04) : 597 - 609
[7] Germline testing for predisposition to breast/ovarian cancer should only be offered to selected patients with epithelial ovarian cancer
Nag S.
Sinukumar S.
Hegde S.
Indian Journal of Gynecologic Oncology, 2017, 15 (Suppl 1) : S31 - S36
[8] Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients
Isiklar, Aysun Dauti
Aliyeva, Lamiya
Yesilyurt, Ahmet
Soyder, Aykut
Basaran, Gul
BREAST CANCER RESEARCH AND TREATMENT, 2023, 202 (02) : 297 - 304
[9] Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients
Aysun Dauti Isiklar
Lamiya Aliyeva
Ahmet Yesilyurt
Aykut Soyder
Gul Basaran
Breast Cancer Research and Treatment, 2023, 202 (2) : 297 - 304
[10] Frequency of somatic and germline variants of predisposition genes in young Chinese women with breast cancer
Xu, Yuchun
Cai, Qindong
Li, Jing
Guo, Wenhui
Chen, Lili
Chen, Minyan
Lin, Yuxiang
Wang, Yali
Cai, Weifeng
Qiu, Yibin
He, Peng
Liu, Shunyi
Wang, Chuan
Fu, Fangmeng
BREAST CANCER RESEARCH AND TREATMENT, 2025, : 635 - 644

← 1 2 3 4 5 →